DAP Guidelines and Whether Change is Needed
The use of dual anti platelet therapy is popular among cardio patients but questions remain of how long that therapy should continue after a cardiac event.
The use of dual anti platelet therapy is popular among cardio patients but questions remain of how long that therapy should continue after a cardiac event.
Robert Yeh, MD, MPH, from Massachusetts General Hospital discussed the results of a study on the topic at the American College of Cardiology Annual Scientific Sessions and Expo in San Diego.
Related Videos
Related Content
